Objectives: To characterize UK clinical isolates of Enterobacteriaceae producing OXA-48-like carbapenemases and to compare their resistance plasmids.
Introduction
Carbapenems have the broadest spectrum of all b-lactam antibiotics and are increasingly used to treat infections caused by otherwise multidrug-resistant Gram-negative bacteria. Consequently, emerging resistance to carbapenems is a major public health concern, especially when it involves acquired, horizontally transmissible carbapenemases. These enzymes are diverse, belonging to classes A, B or D of the Ambler b-lactamase classification. Acquired class D carbapenemases are encountered most often in isolates of Acinetobacter spp., where OXA-23, -40 and -58 variants are all important; however, the genes encoding the OXA-48-like subgroup, which originally escaped from environmental bacteria of the genus Shewanella, 1,2 are increasingly detected in clinical Enterobacteriaceae.
OXA-48 b-lactamase was initially identified in Turkey, 3 but there are now multiple reports of its production, mainly by Klebsiella pneumoniae isolates, from countries in the Middle East, North Africa and, increasingly, Europe. 4 -10 Hospital outbreaks by producers of this carbapenemase have been described in Turkey 6 and, more recently, in the UK, 11 France, 12 Spain, 13 Ireland, 14 The Netherlands 15 and Belgium. 16 K. pneumoniae of sequence type (ST) 395 has been implicated in the European spread of OXA-48 carbapenemase, 17 although the bla OXA-48 gene has been detected in other clones and, indeed, other genera. The gene is usually located on transposon Tn1999, 5 which has been found in OXA-48-positive Enterobacteriaceae of diverse geographic origin on highly related plasmids of 62 kb. 4 -6,12,13,18,19 A recently described variant, OXA-181, from India, differs from OXA-48 by just four amino acids, but its gene is associated with an ISEcp1 element on a distinct transposon, Tn2013, carried on much smaller plasmids of 7.6 kb. 20 It is inferred to represent a separate genetic escape from Shewanella spp. 21 We sought to characterize a representative group of these in greater detail.
Materials and methods
Twenty-six of 94 isolates known to produce OXA-48-like carbapenemases (based on PCR results) and representing referrals from diverse UK hospitals (n¼22) in 2007-11 were selected from the collection of carbapenemase producers held by the HPA's Antibiotic Resistance Monitoring and Reference Laboratory. They comprised 14 isolates of K. pneumoniae, 10 E. coli and two E. cloacae from urine (14) , blood (5), wounds (4), drain fluid (2) and sputum (1) . Twenty-three were from separate inpatients and three-K. pneumoniae KP16, E. coli EC25 and E. cloacae ENT26-were from urine samples collected from a single patient in outpatient clinic and general practitioner (GP) settings over a period of 3 -4 months. Only 4/24 patients were known to have recent travel historytwo to Turkey, one to India and one to Pakistan-though we cannot exclude unreported travel by others.
MICs were determined by BSAC agar dilution and were interpreted according to BSAC/EUCAST criteria (www.eucast.org). The presence of a bla OXA-48-like carbapenemase gene was confirmed by PCR followed by sequencing. 22 PCR was also used to screen for ISEcp1 and IS1999 elements, as previously described. 22 The presence of other b-lactamase genesbla TEM , bla SHV , bla CTX-M group-1 , bla CTX-M group-9 , bla OXA-1 and bla OXA-9 -was also sought, as these genes have been previously reported in Enterobacteriaceae producing OXA-48 enzyme. 5 -7,11,12 Multilocus sequence typing (MLST) was used to assess the relatedness of K. pneumoniae (www.pasteur.fr/recherche/genopole/PF8/mlst) and E. coli (http://mlst.ucc. ie/) isolates, with STs assigned using online database tools.
Plasmids were extracted by alkaline lysis and transformed into electro-competent E. coli DH5a cells (Bioline, London, UK). Transformants were selected on nutrient agar by picking colonies growing within zones of inhibition of piperacillin/tazobactam 75+10 mg discs and screening these for bla OXA-48-like by PCR. Plasmids were re-extracted from transformants and compared after digestion with EcoR1 (Sigma-Aldrich, Poole, UK). PCR-based replicon typing (PBRT) was used to identify plasmid incompatibility groups. 23 The repA, traU and parA genes encoding proteins involved in plasmid replication, transfer and partitioning were sought in transformants or, where necessary, in the clinical isolates, using published primers to compare plasmids with the IncL/M plasmid pOXA-48a. 18 Associations of bla OXA-48-like genes with insertion sequences were tested by PCR mapping, 21 followed by sequencing of selected amplicons. In addition, conjugation experiments were performed to assess the selftransferability of plasmids carrying the bla OXA-48-like genes, using selected clinical isolates and/or transformants as donors and E. coli J53 as the recipient. Transconjugants were selected on nutrient agar supplemented with rifampicin 250 mg/L and ampicillin 100 mg/L.
Results
PCR and sequencing confirmed that 25 of the 26 isolates harboured a classical bla OXA-48 gene, although one K. pneumoniae isolate (KP19), from a patient with a history of travel to India, harboured bla OXA-181 . All were non-susceptible to ertapenem (MICs 1 to .16 mg/L), ampicillin, amoxicillin/clavulanate, piperacillin and piperacillin/tazobactam (MICs .64 mg/L). However, 18 remained susceptible in vitro to meropenem (MICs ≤4 mg/L) and 13 to imipenem (MICs ≤2 mg/L). Neither OXA-48 nor OXA-181 carbapenemase hydrolyse oxyimino-cephalosporins efficiently, 19 yet 21/26 isolates were resistant to cefotaxime (MICs 2 to .256 mg/L), 17 to aztreonam (MICs 4 to .64 mg/L) and 15 to ceftazidime (MICs 2 -256 mg/L), reflecting the frequent presence of extended-spectrum b-lactamases (ESBLs) ( Table 1) . Genes encoding group 1 or 9 CTX-M ESBLs were detected in 10 and 6 isolates, respectively, and these 16 isolates were more resistant to cephalosporins than the remaining 10 isolates, all of which remained susceptible or showed only intermediate susceptibility to cefotaxime and/or ceftazidime ( Carbapenemase-encoding plasmids were transformed into E. coli DH5a using DNA extracted from 21/25 OXA-48-positive isolates and from the single OXA-181 producer, with the presence of bla OXA-48-like confirmed in the transformants by PCR. Despite repeated attempts, transformants were not obtained using DNA extractions from any of the four E. coli isolates belonging to ST38. Most (20/21) of the OXA-48 transformants and the single OXA-181 transformant had reduced susceptibility to carbapenems, resistance to ampicillin, amoxicillin/clavulanate, piperacillin and piperacillin/tazobactam (MICs 32 to .64 mg/L), and susceptibility to the other agents tested ( Table 2) . Eighteen of the 21 OXA-48-positive transformants harboured a single plasmid of 62 kb, and 2 harboured a smaller plasmid of 50 kb. The remaining OXA-48-positive transformant (T24) additionally gained resistance to expanded-spectrum cephalosporins, aztreonam and aminoglycosides. It contained an 140 kb plasmid with bla OXA-9 and a group 9 bla CTX-M gene along with bla OXA-48 , consistent with its broader resistance phenotype. The OXA-181-positive transformant gained a plasmid of 7 kb and acquired resistance only to carbapenems (MICs .16 -128 mg/L), penicillins and penicillin/b-lactamase inhibitor combinations.
Plasmid restriction analysis (data not shown) indicated that the 62 kb OXA-48-encoding plasmids were all highly related, whereas the 50 kb and 140 kb plasmids appeared dissimilar ( Table 2 ). All of these plasmids were transferable by conjugation to E. coli J53. However, no OXA-48-positive transconjugants were obtained when E. coli of ST38 were used as donors, which is consistent with the lack of transformants from these isolates. The 7 kb OXA-181-encoding plasmid had a distinct restriction profile (KP19) and also could not be transferred by conjugation.
None of the plasmids could be assigned to an incompatibility group by the PBRT method. Plasmid pOXA-48a, which is an IncL/ M-type plasmid, albeit not typeable by the PBRT method, OXA-48-like carbapenemases in the UK pHK-NDM. 18 We detected the repA, traU and parA genes of plasmid pOXA-48a 19 in 20/21 transformants with OXA-48 enzyme, suggesting that these 20 plasmids had an IncL/ M-pOXA-48a-like backbone. The remaining OXA-48 transformant, with a 50 kb plasmid from isolate EC10, and the four E. coli clinical isolates of ST38 gave products only with parA primers ( Table 2 ). The transformant from KP19 with OXA-181 enzyme gave no PCR products with any of the primers.
The genetic environments of the bla OXA-48-like genes were determined using combinations of primers specific for an insertion sequence and the carbapenemase gene. Sequencing indicated that the bla OXA-48 genes were flanked by upstream and downstream copies of IS1999; in six isolates the upstream copy was intact, corresponding to transposon Tn1999, 22 whereas 19 had a Tn1999.2 transposon in which the IS1999 sequence is disrupted by an IS1R element. 6 The single OXA-181-positive isolate lacked IS1999, and had an ISEcp1 element immediately upstream of the bla OXA-181 gene, as reported previously.
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K. pneumoniae KP16, E. coli EC25 and E. cloacae ENT26 were recovered from the urinary tract of the same patient, but exhibited different susceptibility profiles to cephalosporins, reflecting the presence of different additional b-lactamases (Table 1 ). All carried indistinguishable 70 kb plasmids, with bla OXA-48 as part of a Tn1999.2 element. Notably EC25 and ENT26 were isolated 3 -4 months after KP16.
Discussion
We have shown that OXA-48 carbapenemase is becoming scattered in the UK, not only in K. pneumoniae, but also in E. coli and E. cloacae. Producers from multiple UK hospitals represented diverse STs. We did not detect K. pneumoniae ST395, which has been implicated in clonal outbreaks elsewhere in Europe, 17 but did find E. coli ST38, reported previously with OXA-48 carbapenemase in France. 18, 19 The data support multiple origins or repeated introduction to the UK of bacteria with the bla OXA-48 gene.
Despite this clonal diversity, we demonstrated that emergence of OXA-48 carbapenemase in the UK has been facilitated by horizontal transfer between strains and genera of successful and related plasmids, most of which were similar to pOXA-48a 18 and others identified previously in many countries, especially in Europe and the Mediterranean region. 4 -6,8,12,13 Consistent with the molecular epidemiological evidence, the 50 kb, 62 kb and 140 kb plasmids were all transferable in vitro by conjugation. Isolation of three OXA-48-positive isolates of K. pneumoniae, E. coli and E. cloacae from a single patient further suggests that this plasmid can transfer successfully in vivo. The location of bla OXA-48 and its associated Tn1999.2 element in E. coli of ST38 requires further study since plasmids could not be transferred from any of four isolates by transformation or conjugation; this contrasts with a previous report in which ST38 E. coli transferred bla OXA-48 in association with a 62 kb plasmid. 18, 19 Plasmids encoding OXA-48 carbapenemase often do not carry other resistance determinants, 19 and so confer resistance only to penicillin/inhibitor combinations and carbapenems. Therefore, some OXA-48 producers remain susceptible to oxyimino-cephalosporins, which offer potential therapeutic options in these cases. The resulting carbapenem-resistant, cephalosporin-susceptible phenotype is not attributed reliably to carbapenemase production by automated systems, 24 and is perhaps not believed by some microbiologists who encounter it in classical susceptibility testing; consequently there is concern that such strains may pass unrecognized in diagnostic laboratories. Accurate detection is further complicated, since many OXA-48 producers remain susceptible or intermediate in vitro to imipenem and meropenem. Recently Glupczynski et al. 16 have suggested that temocillin could be a sensitive screening tool for difficult-to-detect OXA-48-producing Enterobacteriaceae in Belgium, which is noteworthy, as temocillin is also used in the UK. A combination of an OXA-48-encoding plasmid with other resistance mechanisms, principally ESBLs, leads to broader resistance and more reliable detection, but leaves fewer therapeutic options. Of concern, we identified a larger OXA-48-encoding plasmid that also carried a gene for a group 9 CTX-M ESBL in one isolate of K. pneumoniae. A further concern is our detection of bla in an E. coli isolate of the uropathogenic clone ST131, which has achieved notoriety for its role in the rapid global dissemination of ESBLs, especially CTX-M-15, including in community settings. 25 The present finding adds to a growing number of reports that this clone can host carbapenemases, also including NDM and KPC types. 26, 27 Its potential to serve as a vehicle for hospital-community spread of carbapenemases is profoundly alarming. This is also the first known report of a bacterial isolate producing OXA-181 carbapenemase in the UK. The isolate came from a patient with recent travel to India, supporting the link, demonstrated by others, 2, 28 between this resistance determinant and the Indian subcontinent; it has also been identified in New Zealand, in a patient previously hospitalized in Nepal and Thailand. 29 Perhaps significantly, this isolate displayed higher levels of carbapenem resistance than most producing the OXA-48 enzyme.
In summary, the scatter and diversity of Enterobacteriaceae producing OXA-48 carbapenemase in the UK demonstrates that this easily missed resistance is probably distributed more widely than is currently recognized. The 'Mediterranean region', including North African countries and the Middle East are the 'cradle' of bla OXA-48 , but international studies will be needed to confront its continued diffusion, especially in view of the population movements triggered by unrest and revolution in North Africa. There is already a published report of its import, via a war casualty, from Libya to Slovenia, 30 
